FDA Approves Control IQ

Exciting news as the FDA has approved Control IQ from Tandem, offering patients another automated insulin delivery option that has been long awaited. With impressive stability demonstrated over 24 hours, this development is a significant win for both Tandem and the diabetes community. The combination of Control IQ and the Dexcom G6 sensor promises to enhance the management of Type 1 diabetes.